DOCSLIB.ORG

Troikaa Pharmaceuticals Ltd's Drugs List Anaesthetics

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Troikaa Pharmaceuticals Ltd's Drugs List Anaesthetics Troikaa Pharmaceuticals Ltd's Drugs List Anaesthetics Sr.No Product Name /Brand Name Strength/ Composition Presentation Dosage Form Choline Salicylate Solution equivalent to Choline Salicylate 8.7% w/w + 1 ALCINIL 10GM TUBE 1 TUBE TUBE BenzalkoniumChloride solution 0.01%w/w + Lignocaine Hcl 2% w/w Bupivacaine HCl Preservative 2 Free 0.5% Inj. 5 mg / ml 20 ml Vial Injection BUPIPTROY PF Bupivacaine HCl 0.5% Inj. 3 5 mg / ml 20 ml Vial Injection BUPITROY Bupivacaine HCl in Dextrose 4 Inj. 20 mg + 320 mg 5 X 4 ml Amp Injection BUPITROY-HEAVY 5 ml & 10 ml Midazolam Inj. a) 1 mg / ml 5 vial Injection BENZOSED b) 5 mg / ml 3 ml Amp Dexmedetomidine 50 mcg/0.5 6 DEXIT 50 1X0.5 ML 1X0.5 ML AMPOULE ml 7 DEXIT 100 1X1 ML Dexmedetomidine 100 mcg/1 ml 1X1 ML AMPOULE 8 DEXIT 200 1X2 ML Dexmedetomidine 200 mcg/2 ml 1X2 ML AMPOULE Isoflurane 100 ml / 250 ml Volatile liquid 9 ISOTROY 100 ml & 250 ml Bottle for Inhalation 10 ISOTROY 30ML 1X30ML Isoflurane 30 Ml 1X30ML BOTTLE Ketamine Inj. 11 KETAMAX-50 50 mg / ml 10 ml Vial Injection Rocuronium Nbromide Inj. 12 10 mg / ml 5 ml Vial Injection ROCUTROY 50 ml / 250 ml Sevoflurane Volatile liquid 13 50 ml & 250 ml Bottle SEVOTROY for Inhalation Suxamethonium Chloride Each ml contains 10 ml clear glass 14 Injection B.p Suxamethonium Chloride 50 mg Injection vial SUXATROY Propofol Inj. 20 ml / 50 ml 15 10mg / ml - 20 ml / 50 ml Vial Injection TROYPOFOL Vial Propofol MCT Inj. 16 TROYPOFOL MCT 10mg / ml - 20 ml Vial 20 ml Vial Injection Etomidate Emulsion Inj. 17 TROYMIDATE 2mg / ml - 10 ml Vial 10 ml Vial Injection Atracurium Besilate Inj. 18 TROYCURIUM 10 mg / ml 5 X 2.5 ml Amp Injection Fentanyl Citrate Inj. 5 x 2 ml Amp 19 TROFENTYL 50 mcg / ml 5 x 10 ml Amp Injection Each ml contains: Bupivacaine Hydrochloride 1.25 mg TROFENTYL PLUS 0.125% Eq. to anhydrous Bupivacaine 20 1X20ML LIQUID VIAL 1X20ML Hydrochloride 1.185 mg Fentanyl Citrate eq. Fentanyl 2.0 mcg Each ml contains: Bupivacaine Hydrochloride 1.00 mg Eq. to anhydrous Bupivacaine 21 TROFENTYL PLUS 0.1% 1X20ML 1X20ML LIQUID VIAL Hydrochloride 0.948 mg Fentanyl Citrate eq. Fentanyl 2.0 mcg Oral Transmucosal Fentanyl Oral Solid Each Lozenge contains : Fentanyl 1 Lozenge 200 22 Citrate Lozenge (Lozenge) Citrate 200 mcg mg TROFENTYL OTFC Oral Solid Lidocaine Lozenge Each Lozenge contains : (Lozenge) 1 Lozenge 200 23 XYNOVA ENDO Lidocaine 200 mg mg Lidocaine HCl Inj. 24 21.3 mg / ml 30 ml Vial Injection XYNOVA 2% Lidocaine HCl and 25 Adrenaline Inj. 21.3 mg + 0.005 mg / ml 30 ml vial Injection XYNOVA 2% ADRENALINE Antibiotics Sr.No Product Name /Brand Name Strength/ Composition Presentation Dosage Form Amikacin 500Mg + 26 AMITROY 500MG 1 VIAL Methylparaben 0.04% + Propyl 1 VIAL LIQUID VIAL Paraben 0.02% Injection AUGUKA 625 MG TABLETS Amoxycillin 500Mg + Clavulanic 27 10X6 TAB TABLET (10X6 TAB) Acid 125Mg Tablet AMOXYCILLIN & POTASSIUM 28 AUGUKA CV DRY SYRUP 30ML CLAVULANATE ORAL 1X30ML SYRUP SUSPENSION 228.5MG 29 AZIKAA 250 MG 10X6 Tab Azithromycin 250Mg Tablet 10X6 TAB TABLET 30 AZIKAA 500 MG 10X3 Tab Azithromycin 500Mg Tablet 10X3 TAB TABLET Azithromycin Anhydrate 100mg 31 AZIKAA READYMIX 15 ML 1 BOTTLE SUSPENSION Susp 32 AZIKAA DS 15 ML Azithromycin 200mg Susp 1 BOTTLE SUSPENSION Clindamycin 1% w/w + 33 ACNETROY GEL 20GM TUBE 1 TUBE TUBE Nicotinamide 4% w/w Amoxicillin 1000Mg + Clavulanic 34 AUGUTROY 1.2GM 1 VIAL 1 VIAL POWDER VIAL Acid 200Mg Injection Cefoperazone 500Mg + 35 CEFOTROY-SB 1GM VIAL 1 VIAL POWDER VIAL Sulbactum 500 Mg Injection 36 C-ROXIM 250MG 10X1X4 TAB Cefuroxime 250mg Tablet 10X1X4 Tab TABLET 37 C-ROXIM 500MG 10X1X4 TAB Cefuroxime 500mg Tablet 10X1X4 Tab TABLET Cefuroxime Sodium 1.5 Gm. 38 C ROXIM 1.5GM 1 VIAL 1 VIAL POWDER VIAL Injection Cefuroxime Sodium 750 mg 39 C ROXIM 750MG 1 VIAL 1 VIAL POWDER VIAL Injection 40 CIPROCIN 250 30X10 TAB Ciprofloxacin 250mg Tablet 30X10 Tab TABLET 41 CIPROCIN 500 30X10 TAB Ciprofloxacin 500mg Tablet 30X10 Tab TABLET Imipenem 500 Mg + Cilastatin 42 CILASPEN 1 VIAL 1 VIAL POWDER VIAL 500 Mg Injection CEFOTROY-SB FORTE 1.5 GM Cefoperazone 1000Mg + 43 1 VIAL POWDER VIAL INJ. Salbactum 500Mg Injection Clotrimazole 200mg + Tinidazole500Mg + Povidone 44 CLOTROY PLUS 1X6 TAB 1X6 TAB TABLET Iodine 200mg + Lactic acid 150 million spores Tablet Clotrimazole 200Mg + Tinidazole 45 CLOTROY PLUS NF 10X1X6 TAB 600Mg + Povidone Iodine 10X1X6 TAB TABLET 200Mg Tablet Colistimethate Sodium 46 COLISTROY 1 MIU 1 Vial POWDER VIAL 10,00,000 IU Injection Colistimethate Sodium 47 COLISTROY 2 MIU 1 Vial POWDER VIAL 20,00,000 IU Injection Colistimethate Sodium 48 COLISTROY 3 MIU 1 Vial POWDER VIAL 30,00,000 IU Injection Clotrimazole 1% w/w + Beclomethasone dipropionate 49 DERMINOVA-SN 15GM 1 TUBE 0.025% w/w +Neomycin 1X15GM TUBE sulphate eq. to Neomycin 0.5% w/w Cream 50 FORTACEF 1 GM 1 VIAL Ceftazidime 1Gm Injection 1 VIAL POWDER VIAL LEVOTROY 250 MG 10X1X10 51 Levofloxacin 250mg Tablet 10X1X10 TAB TABLET Tab LEVOTROY 500MG TAB. 52 Levofloxacin 500mg Tablet 2X10X5 TAB TABLET (2X10X5) Linezolid 600 mg Tablet Blister of Each tablet contains : Linezolid Oral Solid 53 LINOZID 4 Tablets 600 mg Meropenem 1Gm per vial 54 MEROBID 1GM INJ (1 VIAL) 1 VIAL POWDER VIAL Injection Norfloxacin 400 mg + Tinidazole 55 NORTIKAA 20X10 TAB 20X10 Tab TABLET 600 mg Tablet 56 OPTIMOX 250MG 30X10 CAPS Amoxycillin 250mg Capsule 30X10 CAP CAPSULE OPTIMOX 250MG DT 30X10 Amoxycillin Trihydrate 250mg 57 30X10 TAB TABLET TABS Tablet 58 OPTIMOX 500MG 20X10 CAPS Amoxycillin 500mg Capsule 20X10 CAP CAPSULE OPTIMOX CV 625MG 10x1x6 Amoxycillin 500Mg + Clavulanic 59 10X1X6 TAB TABLET TABS Acid 125Mg Tablet OPTIMOX CV DRY SYRUP 30ML Amoxycillin 200mg + Clavulanic 60 1 BOTTLE SYRUP (W-WFI) Acid 28.5Mg Syrup Amoxicillin 1000Mg + Clavulanic 61 OPTIMOX CV 1.2GM 1 VIAL 1 VIAL POWDER VIAL Acid 200Mg Injection 62 ROXIKAA 150 MG 20X10 Tab Roxithromycin Tablet 150 Mg 20X10 TAB TABLET Each capsule Contains : Nitrofurantoin SR Capsule Blister of Nitrofurantoin SR 100 mg 63 TROYDANTIN 10 Capsule Oral Solid 64 TROYAXONE 1GM INJECTION Ceftriaxone 1Gm. Injection 1 VIAL POWDER VIAL Ceftriaxone 1Gm + Sulbactum 65 TROYAXONE S 1.5GM 1 VIAL 1 VIAL POWDER VIAL 500Mg Injection TROYPENEM 1000 MG INJ. 1 Meropenem 1Gm per vial 66 1 VIAL POWDER VIAL VIAL Injection TROYPENEM 500 MG INJ. 1 67 Meropenam 500Mg Injection 1 VIAL POWDER VIAL VIAL TROYPERAZONE S 1.5 GM 1 Cefoperazone 1000Mg + 68 1 VIAL POWDER VIAL VIAL Salbactum 500Mg Injection Piperacillin 4GM + Tazobactum 69 TROYPIPERA T 4.5 GM 1 VIAL 1 VIAL POWDER VIAL 0.5GM per Vail Injection 70 TROYPLANIN 400MG. 1 VIAL Teicoplanin 400Mg Injection 1 VIAL POWDER VIAL Cefoperazone 500Mg + 71 TROYPERAZONE S 1GM 1 VIAL 1 VIAL POWDER VIAL Sulbactum 500 Mg Injection 72 TROFLOCIN 200 MG 20X10 TAB Ofloxacin 200 mg Tablet 20X10 Tab TABLET 73 TROFLOX 200MG 20X10 TABS Ofloxacin 200 mg Tablet 20X10 Tab TABLET Ofloxacin 200mg + Ornidazole 74 TROFLOX OZ 20X10 TABS 20X10 Tab TABLET 500mg Tablet 75 TROFLOX SUSPENSION 60ML Ofloxacin 50mg per 5 ML 1 BOTTLE SUSPENSION 76 TROYDROX 250MG 20X10 TABS Cefadroxil 250Mg Tablet TABLET 77 TROYDROX 500MG 20X10 TABS Cefadroxil 500Mg Tablet TABLET TROYGEN-TZ INJECTION (1 Piperacillin 4GM + Tazobactum 78 1 VIAL POWDER VIAL VIAL) 0.5GM per Vial Injection Gentamycin Sulphate IP. Inj. 79 TROYGENTA 20ML 1X24 VIAL 1X24 VIAL LIQUID VIAL (40mg/ml - 20 ml) Gentamicin Sulphate IP Injection 80 TROYGENTA 2ML 1X96 VIAL 1X96 VIAL LIQUID VIAL (40 mg/ml - 2 ml) Cefpodoxim Proxitel Tablet 81 TROYPOD 100 MG 10X1X10 Tab 10X1X10 TAB TABLET 100Mg Cefpodoxim Proxitel Tablet 82 TROYPOD 200 MG 10X1X10 Tab 10X1X10 TAB TABLET 200Mg Cefpodoxime 200 Mg + 83 TROYPOD CV 325 10x6 TABS 10X6 TAB TABLET Clavulanic Acid 125 Mg Tablet TROYPOD DRY SYRUP 30 ML 84 Cefpodoxim Dry Syrup 30Ml 1 BOTTLE SYRUP SALE PACK TROYZOLID 600MG TABLETS 85 Linezolid 600mg Tablet 10X1X4 Tab TABLET 10X1X4 86 TROYZOLID 10X1X4TAB Linezolid 600mg Tablet 10X1X4 TAB TABLET LINEZOLID IV INJECTION 2MG/ML Each 100ml contains: 87 TROYZOLID INFUSION 300ML 1 BOTTLE BOTTLE Linezolid 200mg + Dextrose (Anhydrous) 5% w/v Water for injection 88 TROYZONE 1.0 GM INJ. Ceftriaxone 1Gm. Injection 1 VIAL POWDER VIAL Ceftriaxone 1Gm + Sulbactum 89 TROYZONE SB 1.5GM 1 VIAL 1 VIAL POWDER VIAL 500Mg Injection Ceftriaxone 1Gm. + Tazobactam 90 TROYZONE-TZ 1.125 GM 1 VIAL POWDER VIAL 125mg Injection 91 TROYZIDE 1 GM 1 VIAL Ceftazidime 1Gm Injection 1 VIAL POWDER VIAL 92 TROYRIFAXI 10X1X10 TAB Rifaximin 400mg Tablet 10X1X10 TAB TABLET 93 VANCOTROY 500MG 1 VIAL Vancomycin 500Mg Injection 1 VIAL POWDER VIAL 94 ZIM 100MG 10X10 TAB Cefixime 100Mg Tablet 10X10 TAB TABLET 95 ZIM 200 MG 10X10 TABS Cefixime 200Mg Tablet 10X10 TAB TABLET 96 ZIM 50MG 10X10 TAB Cefixime 50Mg Tablet 10X10 TAB TABLET Cefixime as Trihydrate 200mg + 97 ZIMCLAV 325 10x1x6 TABS Potassium Clavulanate Diluted 10X1X6 TAB TABLET 125mg Tablet Cefixime Trihydrate 200mg + 98 ZIM- O 10X10 TABS 10X10 TAB TABLET Ofloxacin 200mg Tablet Cefixime (as Trihydrate) Equivalent to anyhydrous 99 ZIM- O DRY SYRUP 30 ML 1 BOTTLE SYRUP Cefixime 50MG; Ofloxacin 50MG Excipients q.s. per 5 ML Cefixime Trihydrate Equivalent 100 ZIMTROY 30 ML DRY SYRUP 1 BOTTLE SYRUP to Cefixime 50Mg per 5 ML Anti-Ulcerants Sr.No Product Name /Brand Name Strength/ Composition Presentation Dosage Form Triamcinolone Acetonide 101 KENATROY 1ML INJECTION Injection + Intramuscular 40 1 INJECTION LIQUID VIAL Mg/Ml Ranitidine Hydrochloride 168 102 NILCER 150MG 20X3X10 TABS mg equivalent to Ranitidine 150 20X3X10 TAB TABLET mg Tablet Ranitidine 150mg + 103 NILCER D 20X3X10 TABS 20X3X10 Tab TABLET Domperidone 10mg Tablet Omeprazole Delayed Release Each Capsule contains: Blisters of 10 Capules Omeprazole 20 mg 104 Capsules Oral Solid OMEKAA OMEKAA-D CAPSULE 25X10 Omeprazole 20mg + 105 25X10 CAP CAPSULE SALE PACK Domperidon 10mg Capsule Pantoprazole 40 mg pellets + 106 PANOTROY DSR 10x10 CAPS Domperidone 30 mg pallets 10X10 CAP CAPSULE Capsule Pantoprazol 40mg/10Ml 107 PENTAZOL 40MG INJ.
Load more

Recommended publications
  • Use of Chemical Chelators As Reversal Agents for Drug
    (19) TZZ_ _ZZZ_T (11) EP 1 210 090 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.: of the grant of the patent: A61K 31/724 (2006.01) A61K 31/194 (2006.01) 18.06.2014 Bulletin 2014/25 A61P 39/04 (2006.01) (21) Application number: 00964006.1 (86) International application number: PCT/EP2000/007694 (22) Date of filing: 07.08.2000 (87) International publication number: WO 2001/012202 (22.02.2001 Gazette 2001/08) (54) USE OF CHEMICAL CHELATORS AS REVERSAL AGENTS FOR DRUG- INDUCED NEUROMUSCULAR BLOCK VERWENDUNG VON CHEMISCHEN CHELATOREN ZUR UMKEHRUNG VON PHARMAKOLOGISCH-INDUZIERTER NEUROMUSKULÄRER BLOCKIERUNG UTILISATION D’AGENTS CHIMIQUES CHELATANTS COMME AGENTS DE NEUTRALISATION DU BLOCAGE NEUROMUSCULAIRE PROVOQUE PAR DES MEDICAMENTS (84) Designated Contracting States: (56) References cited: AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU AU-A- 3 662 895 MC NL PT SE • B DESIRE: "Inactivaton of sarin and soman by (30) Priority: 13.08.1999 EP 99306411 cyclodextrins in vitro" EXPERIENTIA, vol. 43, no. 4, 1987, pages 395-397, XP000907287 (43) Date of publication of application: • B. DESIRE: "Interaction of soman with beta- 05.06.2002 Bulletin 2002/23 cyclodextrin" FUNDAMENTAL AND APPLIED TOXICOLOGY, vol. 7, no. 4, 1986, pages 647-657, (73) Proprietor: Merck Sharp & Dohme B.V. XP000911170 2031 BN Haarlem (NL) • C. MAY: "Development of a toxin-binding agent as a treatment for tunicamycinuracil toxicity: (72) Inventors: protection against tunicamycin poisoning of • BOM, Antonius, Helena, Adolf sheep" AUSTRALIAN VETERINARY JOURNAL, Ratho, Midlothian EH28 8NY (GB) vol. 76, no.
    [Show full text]
  • Comparative Study of Different Doses of Rocuronium Bromide For
    MedDocs Publishers Annals of Anesthesia and Pain Medicine Open Access | Research Article Comparative study of different doses of rocuronium bromide for endotracheal intubation Nidhi V Sardhara1*; Sonal A Shah2; Dhaval P Pipaliya3; Shivansh Gupta3 1SVP hospital, 13th floor, Room no 13125, Near Ellis bridge, Ahmedabad, Gujarat-380006 2Assistant Professor, Department of anesthesia, Smt. NHL Municipal Medical College, Ahmedabad, Gujarat, India 3First year Resident, Department of anesthesia, Smt. NHL Municipal Medical College, Ahmedabad, Gujarat, India *Corresponding Author(s): Nidhi V Sardhara Abstract SVP hospital, 13th floor, Room no 13125, Near Ellis Background: Endotracheal intubation is one of such bridge, Ahmedabad, Gujarat-380006 development without which general anesthesia cannot be Tel: +91-9428-44-7878, Fax: 7926-57-8452 considered safe for any major surgery particularly head and Email: [email protected] neck, thoracic and abdominal surgeries. Ever since the ad- vent of anesthesia, anesthesiologists have been in search of an ideal muscle relaxants which can provide ideal intu- bating conditions in ultrashort duration with minimal side effects. Rocuronium bromide provides fast onset of action, Received: Mar 11, 2020 an intermediate duration of action and rapid recovery, good Accepted: Apr 24, 2020 to excellent intubating conditions at doses having minimal Published Online: Apr 30, 2020 or no haemodynamic changes. Present study is to compare the effect of different doses (0.6 mg/kg, 0.9 mg/kg, 1.2 mg/ Journal: Annals of Anesthesia and Pain Medicine kg) of Rocuronium bromide for endotracheal intubation at Publisher: MedDocs Publishers LLC 60 seconds. Online edition: http://meddocsonline.org/ Material and methods: This study was carried out by Copyright: © Sardhara NV (2020).
    [Show full text]
  • Download Document
    FAM001159-0001 intervals of 4-7 days to usual dose of 75-100 mg Dolmatil® (Sanofi-Synthelabo) ~ 100 rag/5 mL, thioridazine 100 rag/ per course and max. 4 injections; max. duration of daily according to response; CHILD not recom- Tablets, both scored, sulpiride 200 rag, net price ’ net price 300 mL = £7.14. Label: 2 treatment 2 weeks---if maintenance treatment mended 100-tabpack=£13.85;400mg(f/c), 100-tab ! fNote. These suspensions should not be diluted but the necessary change to an oral antipsychotic 2-3 Short-term adjunctive management of severe pack = £36¯29. Label: 2 .: :~t~a preparations may be mixed with each other to days after last injection, or to a longer acting anti- anxiety, 15-20rag daily in divided doses; max. Sulpltil® (Pharmacia) I~ ~0iovid¢ intermediate strengths psychotic depot injection given concomitantly 40 mg daily; CHILD not recommended Tablets, scored, sulpiride 200 rag. Net price 28-tab "ff~-~p, brown, thioridazine (as hydrochloride) with last injection of zuclopenthixol acetate; By deep intramuscular injection, psychoses, mania, pack = £4.29; 112-tab pack = £12.85. Label: 2 ~ff.~5"~mg/5 mL, net price 300 mL = £1.98. Label: 2 CHILD not recommended prochlorperazine mesilate 12.5-25 mg 2-3 times Sulpor® (Rosemont) IPoMI Clopi~ol Acuphase® (Lundbeck) daily; CHILD not recommended Oral solution, sugar-free, lemon- and aniseed-fla. LUOPERAZINE Injection (oily), zuclopenthixol acetate 50 mg/mL. By rectum in suppositories, psychoses, mania, the voured, sulpiride 200 mg/5 mL, net price 150 mL (’~’n~ications: see under Dose; anti-emetic (section Net price I-mL amp = £5.20; 2-mL amp = £10.03 equivalent of prochlorperazine maleate 25 mg 2- = £27.00.
    [Show full text]
  • PMBJP Product.Pdf
    Sr. Drug Generic Name of the Medicine Unit Size MRP Therapeutic Category No. Code Analgesic & Antipyretic / Muscle 1 1 Aceclofenac 100mg and Paracetamol 325 mg Tablet 10's 10's 8.00 relaxants Analgesic & Antipyretic / Muscle 2 2 Aceclofenac Tablets IP 100mg 10's 10's 4.37 relaxants Acetaminophen 325 + Tramadol Hydrochloride 37.5 film Analgesic & Antipyretic / Muscle 3 4 10's 8.00 coated Tablet 10's relaxants Analgesic & Antipyretic / Muscle 4 5 ASPIRIN Tablets IP 150 mg 14's 14's 2.70 relaxants DICLOFENAC 50 mg+ PARACETAMOL 325 mg+ Analgesic & Antipyretic / Muscle 5 6 10's 11.30 CHLORZOXAZONE 500 mg Tablets 10's relaxants Diclofenac Sodium 50mg + Serratiopeptidase 10mg Tablet Analgesic & Antipyretic / Muscle 6 8 10's 12.00 10's relaxants Analgesic & Antipyretic / Muscle 7 9 Diclofenac Sodium (SR) 100 mg Tablet 10's 10's 6.12 relaxants Analgesic & Antipyretic / Muscle 8 10 Diclofenac Sodium 25mg per ml Inj. IP 3 ml 3 ml 2.00 relaxants Analgesic & Antipyretic / Muscle 9 11 Diclofenac Sodium 50 mg Tablet 10's 10's 2.90 relaxants Analgesic & Antipyretic / Muscle 10 12 Etoricoxilb Tablets IP 120mg 10's 10's 33.00 relaxants Analgesic & Antipyretic / Muscle 11 13 Etoricoxilb Tablets IP 90mg 10's 10's 25.00 relaxants Analgesic & Antipyretic / Muscle 12 14 Ibuprofen 400 mg + Paracetamol 325 mg Tablet 10's 15's 5.50 relaxants Analgesic & Antipyretic / Muscle 13 15 Ibuprofen 200 mg film coated Tablet 10's 10's 1.80 relaxants Analgesic & Antipyretic / Muscle 14 16 Ibuprofen 400 mg film coated Tablet 10's 15's 3.50 relaxants Analgesic & Antipyretic
    [Show full text]
  • Suxamethonium Chloride 2016
    SUXAMETHONIUM CHLORIDE 2016 Alert Intubation, suction and ventilation equipment MUST be ready prior to administration of suxamethonium. A medical officer/nurse practitioner (preferably two personnel) experienced in advanced neonatal airway management techniques should be present when the medication is being administered. Risk of cardiac arrest from hyperkalemic rhabdomyolysis Indication Elective endotracheal intubation. Action Short-acting, depolarising neuromuscular blocker. It acts as an acetylcholine antagonist at nicotinic acetylcholine receptors at neuromuscular junctions, resulting in persistent depolarisation of the motor end plate. Drug Type Neuromuscular blocking agent (depolarising) Trade Name Suxamethonium Chloride Injection BP Presentation 100 mg/2 ml ampoule. Dosage/Interval IV ( preferred): 2 mg/kg (up to 3 mg/kg) IM (only if IV is not accessible): 3–4 mg/kg9 (onset of action can be delayed up to 3 minutes and duration of action is up to 15 minutes) Route IV, IM Maximum Dose IV: 3 mg/kg/dose; IM: 4 mg/kg/dose Preparation/Dilution IV: Draw up 1 mL (50 mg of suxamethonium) and add 9 mL sodium chloride 0.9% to make final volume 10 mL with a concentration of 5 mg/mL. IM: Administer undiluted. Administration IV: Rapid injection at proximal cannula site. IM: Administer in anterior thigh muscle. Monitoring Continuous cardiorespiratory monitoring. Monitor temperature, blood pressure, oxygenation and assisted ventilator status. Contraindications Hyperkalaemia Family history of malignant hyperthermia Skeletal muscle myopathy Hypersensitivity to suxamethonium Precautions Anaphylaxis: Severe anaphylactic reactions (some life-threatening and fatal) have been reported. Cross-sensitivity with other neuromuscular-blocking agents may occur; use extreme caution in patients with previous anaphylactic reactions.
    [Show full text]
  • 10 Mg/Ml Solution for Injection/Infusion Atracurium
    Package leaflet: Information for the patient <Product name> 10 mg/ml solution for injection/infusion Atracurium besilate Read all of this leaflet carefully before you start using this medicine because it contains important information for you. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or nurse. - If you get any side effects, talk to your doctor or nurse. This includes any possible side effects not listed in this leaflet. See section 4. What is in this leaflet 1. What <Product name> is and what it is used for 2. What you need to know before you receive <Product name> 3. How to use <Product name> 4. Possible side effects 5. How to store <Product name> 6. Contents of the pack and other information 1. What <Product name> is and what it is used for <Product name> belongs to a group of medicines called muscle relaxants. <Product name> is used during surgery to relax muscles and to assist with inserting a breathing tube and with artificial breathing. It is also used to help with artificial breathing at patients in intensive care units. 2. What you need to know before you receive <Product name> <Product name> cannot be administered: - if you are allergic to atracurium besilate, cisatracurium or any of the other ingredients of this medicine (listed in section 6). If you think that this applies to you talk to your doctor before <Product name> is administered to you. Warnings and precautions Talk to your doctor or nurse before using <Product name>: - if you have an allergy or bronchial
    [Show full text]
  • (12) United States Patent (10) Patent N0.: US 7,265,099 B1 Born Et A1
    US007265099B1 (12) United States Patent (10) Patent N0.: US 7,265,099 B1 Born et a1. (45) Date of Patent: *Sep. 4, 2007 (54) USE OF CHEMICAL CHELATORS AS Tarver, G. et al “2-O-Substituted cyclodextrins as reversal REVERSAL AGENTS FOR DRUG-INDUCED agents . ” Bioorg. Med. Chem. (2002) vol. 10, pp 1819-1827.* NEUROMUSCULAR BLOCK Zhang, M. “Drug-speci?c cyclodextrins . ” Drugs of the Future (2003) vol. 28, no 4, pp 347-354.* (75) Inventors: Antonius Helena Adolf Bom, Lee, C. “Structure, conformation, and action of neuromuscular Midlothian (GB); Alan William Muir, blocking drugs” Brit. J. Anesth. (2001) vol. 87, no 5, pp 755-769.* Lanark (GB); David Rees, Gothenburg B Desire: “Inactivation of sarin and soman by cyclodextrins in (SE) vitro” EXPERIENTIA, vol. 43, No. 4, 1987, pp. 395-397. B. Desire: “Interaction of soman with beta-cyclodextrin” Funda (73) Assignee: Organon N.V., Oss (NL) mental and Applied Toxicology, vol. 7, No. 4, 1986, pp. 647-657. ( * ) Notice: Subject to any disclaimer, the term of this C. May: “Development of a toxin-bindng agent as a treatment for patent is extended or adjusted under 35 tunicamycinuracil toxicity: protection against tunicamycin poison U.S.C. 154(b) by 0 days. ing of sheep” Australian Veterinary Journal, vol. 76, No. 11, 1998 pp. 752-756. This patent is subject to a terminal dis K. Uekama: “Effects of cyclodextrins on chlorpromaZine-induced claimer. haemolysis and nervous systems responses” J. Pharm. Pharmacol., vol. 33, No. 11, 1981, pp. 707-710. (21) Appl. No.: 10/049,393 T. Irie: “Protective mechanism of beta-cyclodextrin for the hemolysis induced With phenothiazine neuroleptics in vitro” J.
    [Show full text]
  • Malta Medicines List April 08
    Defined Daily Doses Pharmacological Dispensing Active Ingredients Trade Name Dosage strength Dosage form ATC Code Comments (WHO) Classification Class Glucobay 50 50mg Alpha Glucosidase Inhibitor - Blood Acarbose Tablet 300mg A10BF01 PoM Glucose Lowering Glucobay 100 100mg Medicine Rantudil® Forte 60mg Capsule hard Anti-inflammatory and Acemetacine 0.12g anti rheumatic, non M01AB11 PoM steroidal Rantudil® Retard 90mg Slow release capsule Carbonic Anhydrase Inhibitor - Acetazolamide Diamox 250mg Tablet 750mg S01EC01 PoM Antiglaucoma Preparation Parasympatho- Powder and solvent for solution for mimetic - Acetylcholine Chloride Miovisin® 10mg/ml Refer to PIL S01EB09 PoM eye irrigation Antiglaucoma Preparation Acetylcysteine 200mg/ml Concentrate for solution for Acetylcysteine 200mg/ml Refer to PIL Antidote PoM Injection injection V03AB23 Zovirax™ Suspension 200mg/5ml Oral suspension Aciclovir Medovir 200 200mg Tablet Virucid 200 Zovirax® 200mg Dispersible film-coated tablets 4g Antiviral J05AB01 PoM Zovirax® 800mg Aciclovir Medovir 800 800mg Tablet Aciclovir Virucid 800 Virucid 400 400mg Tablet Aciclovir Merck 250mg Powder for solution for inj Immunovir® Zovirax® Cream PoM PoM Numark Cold Sore Cream 5% w/w (5g/100g)Cream Refer to PIL Antiviral D06BB03 Vitasorb Cold Sore OTC Cream Medovir PoM Neotigason® 10mg Acitretin Capsule 35mg Retinoid - Antipsoriatic D05BB02 PoM Neotigason® 25mg Acrivastine Benadryl® Allergy Relief 8mg Capsule 24mg Antihistamine R06AX18 OTC Carbomix 81.3%w/w Granules for oral suspension Antidiarrhoeal and Activated Charcoal
    [Show full text]
  • Zambia Essential Medicine List (Zeml) 03 2013
    ZAMBIA ESSENTIAL MEDICINE LIST (ZEML) 03 2013 Drug Presentation Level VEN 1 Drugs used in anaesthesia 1.1. Drugs used in general anaesthesia 1.1.1 Intravenous and intramuscular anaesthetics 1.1.1.1 Ketamin injection 10mg/ml (10 ml) II-IV V 1.1.1.2 Thiopentone sodium powder for reconstitution 1g and 5g vials II-IV V 1.1.2 Inhalation anaesthetics 1.1.2.1 Halothane inhalation II-IV V 1.1.2.2 Nitrous oxide medical gas II-IV E 1.1.3 Muscle relaxants 1.1.3.1 Suxamethonium chloride injection 50mg/ml, (2ml) II-IV V 1.1.4 Anticholinesterases 1.1.4.1 Neostigmine injection 2.5mg/ml, (1ml) II-IV V 1.2 Drugs used in local anaesthesia 1.2.1. Lignocaine injection 1% (10ml, 50ml) I-IV V 1.2.2 Lignocaine + adrenaline dental cartridge injection 2% (1 in 80,000) II-IV V 1.3 Drugs used in spinal anaesthesia 1.3.1 Bupivacaine/glucose injection 0.5%, (4ml) IV E 1 Drug Presentation Level VEN 2. Drugs acting on the gastrointestinal system 2.1 Antacids 2.1.1 Aluminium hydroxide gel, chewable tablets I-IV E 2.12 Magnesium trisilicate Compound chewable tablets, mixture I-IV E 2.2. Antispasmodics 2.2.1 Hyoscine butyl bromide injection 20mg/ml, (1ml) II-IV E 2.2.2 Propantheline bromide tablets 15mg I-IV E 2.3 Ulcer healing drugs 2.3.1 Cimetidine tablets 200mg II-IV E 2.3.2 Omeprazole tablets 10mg, II-IV E 2.3.3 Ranitidine tablets 150mg II-IV E 2.3.4 Tripotassium dicitratobismuthate tablets 120mg II-IV E 2.3.5 Clarithromycin tablets 250mg II-IV E 2.4.
    [Show full text]
  • 2018 Product List Expertise in Injectables
    2018 Product list Expertise in injectables Flucloxacillin ................................................................................ ................................................... 250 mg Antibiotics ................................................................................ ................................................... Flucloxacillin 500 mg Amoxicillin ....................................................................................... .................................................... 250 mg ................................................................................ .................................................................. Flucloxacillin 1 g Amoxicillin ....................................................................................... .................................................... 500 mg ..................................................................................... .................................................................. Fosfomycin 1 g Amoxicillin ....................................................................................... ................................................................... 1 g ..................................................................................... .................................................................. Fosfomycin 4 g Amoxicillin ....................................................................................... ................................................................... 2 g Gentamicin ......................................................................................
    [Show full text]
  • Summary of Product Characteristics
    Health Products Regulatory Authority Summary of Product Characteristics 1 NAME OF THE MEDICINAL PRODUCT Murexal 10 mg/mL solution for injection in pre-filled syringe 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each mL of solution for injection contains 10 mg of suxamethonium chloride anhydrous (as 11 mg of suxamethonium chloride dihydrate). Each 10 ml pre-filled syringe contains 100 mg of suxamethonium chloride anhydrous (as 110 mg of suxamethonium chloride dihydrate). Excipient with known effect: Each ml of solution for injection contains 2.79 mg equivalent to 0.12 mmol of sodium. Each 10 ml pre-filled syringe contains 27.9 mg equivalent to 1.2 mmol of sodium. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Solution for injection (injection). Clear and colourless solution. pH: 3.0 – 4.5 Osmolality: 250-350 mOsm/Kg 4 CLINICAL PARTICULARS 4.1 Therapeutic Indications Murexal is indicated as a muscle relaxant to facilitate endotracheal intubation during induction of general anaesthesia or emergency situations, in adults and paediatric population above 12 years of age. 4.2 Posology and method of administration Suxamethonium should be administered only by or under close supervision of an experienced clinician (anaesthesist, intensivist, emergency physician) familiar with its action, characteristics and hazards, who is skilled in the management of intubation and artificial respiration and only where there are adequate facilities for immediate endotracheal intubation with administration of oxygen by intermittent positive pressure ventilation. It is given intravenously after anaesthesia has been induced and should not be administered to the conscious patient. Posology Adults To achieve endotracheal intubation, suxamethonium chloride is usually administered by bolus intravenous injection in a dose of 1 mg/kg body weight.
    [Show full text]
  • New Zealand Data Sheet
    NEW ZEALAND DATA SHEET 1. TRACRIUM (atracurium besilate 10 mg/mL injections (2.5 mL and 5.0 mL)) 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each 2.5 mL ampoule contains 25 mg atracurium besilate, each 5 mL ampoule contains 50 mg atracurium besilate. TRACRIUM 2.5 mL and 5.0 mL injections contain no preservative. 3. PHARMACEUTICAL FORM TRACRIUM injection is a clear, faintly yellow, sterile, aqueous solution in a glass ampoule containing 10 mg/mL atracurium besilate. 4. CLINICAL PARTICULARS 4.1 Therapeutic indications TRACRIUM is a highly selective, competitive or non-depolarising neuromuscular blocking agent which is used as an adjunct to general anaesthesia to enable tracheal intubation to be performed and to relax skeletal muscles during surgery or controlled ventilation, and to facilitate mechanical ventilation in Intensive Care Unit (ICU) patients. 4.2 Dose and method of administration Use in adults Injection TRACRIUM is administered by intravenous injection. The dosage range for adults is 0.3 to 0.6 mg/kg (depending on the duration of full block required) and will provide adequate relaxation for 15 to 35 minutes. Endotracheal intubation can usually be accomplished within 90 seconds from the intravenous injection of 0.5 to 0.6 mg/kg. Full block can be prolonged with supplementary doses of 0.1 to 0.2 mg/kg as required. Successive supplementary dosing does not give rise to accumulation of neuromuscular blocking effect. Spontaneous recovery from the end of full block occurs in about 35 minutes as measured by the restoration of the tetanic response to 95% of normal neuromuscular function.
    [Show full text]